Post-Infectious IBS Following Bacterial Gastroenteritis

Pathophysiology and Diagnosis

Up to 27% of patients with completely healed intestinal mucosa still experience persistent bowel symptoms, demonstrating that structural inflammation and functional symptoms are separate entities, according to the American Gastroenterological Association 1
Functional changes in gut neuromotor-sensory function, barrier integrity, and the brain-gut axis rather than visible inflammation contribute to symptoms, as reported by the British Society of Gastroenterology 2
Residual low-grade inflammation with increased mast cells and immune cell activation persists even without visible mucosal damage, as noted by the European Society of Gastrointestinal Motility 2
Increased intestinal permeability allows bacterial products to trigger ongoing immune responses, according to the American Gastroenterological Association 3

Small Intestinal Bacterial Overgrowth (SIBO) occurs in up to 30% of patients with post-infectious symptoms and can cause bloating, pain, and diarrhea, as reported by the American College of Gastroenterology 3
Glucose or lactulose hydrogen breath testing is recommended for SIBO diagnosis, though sensitivity ranges from 20-93%, according to the European Society of Gastrointestinal Motility 3
Serum C4 and FGF19 levels may help diagnose Bile Acid Diarrhea (BAD), though availability varies, as noted by the American Gastroenterological Association 3

A low FODMAP diet should be offered as first-line dietary therapy, with careful attention to nutritional adequacy, as recommended by the American Gastroenterological Association 4
Rifaximin 550 mg three times daily for 14 days (can be repeated up to two additional times for symptom recurrence) is effective for diarrhea-predominant symptoms, according to the American College of Gastroenterology 4
Bile acid sequestrants are recommended if BAD is suspected or confirmed, as noted by the European Society of Gastroenterology 4
Osmotic laxatives (polyethylene glycol) or stimulant laxatives should be offered for constipation-predominant symptoms, as reported by the American Gastroenterological Association 4
Antispasmodics, neuropathic agents (gabapentin, pregabalin), or low-dose antidepressants (tricyclics or SSRIs) should be used for abdominal pain, according to the American College of Gastroenterology 4
Cognitive behavioral therapy, hypnotherapy, or mindfulness therapy should be considered as they address the brain-gut axis dysfunction and have demonstrated efficacy in functional GI disorders, as recommended by the American Gastroenterological Association 4

Do not pursue further endoscopic evaluation unless new alarm features develop (weight loss, bleeding, nocturnal symptoms, fevers), as advised by the American Gastroenterological Association 5
Do not rely on opiates for pain management as they worsen functional GI symptoms and increase complications, according to the American College of Gastroenterology 4
Do not ignore the psychological component—anxiety and depression are both consequences and perpetuating factors in PI-IBS, as noted by the European Society of Gastrointestinal Motility 6

Psychological stress can directly cause elevated intestinal inflammatory markers through multiple biological pathways, typically acting as a trigger or exacerbating factor rather than the sole root cause in most clinical scenarios, as noted by the American Gastroenterological Association 7, 8, 9

Both acute and chronic psychosocial stress are associated with increased circulating levels of inflammatory markers, including C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), according to the Brain, Behavior, and Immunity society 10, 8
Stress activates nuclear factor kappa B (NF-κB), the central mediator connecting inflammation to stress by regulating proinflammatory mediators, including CRP, TNF-α, and multiple interleukins, as reported by the Annual Review of Nutrition 11
Psychological stress creates a unique cytokine milieu favoring Th2 immune responses, which can predispose to enteritis and sustained intestinal inflammation, as found by the American Gastroenterological Association 9

In post-infectious IBS, psychological factors during or preceding infection strongly predict development of persistent intestinal inflammation and elevated inflammatory markers, as noted by the American Gastroenterological Association 7, 9
Stress can be a risk factor for enteritis itself, not just a consequence, particularly when psychological stress precedes gastrointestinal symptoms, according to the American Gastroenterological Association 9
Psychological stress exacerbates gastrointestinal symptoms via alterations in gut motility, epithelial function, and perception of visceral stimuli in patients with underlying intestinal pathology, as reported by the American Gastroenterological Association and the European Gastroenterology society 12, 13

Psychological intervention (psychotherapy, patient education, relaxation techniques) as adjunctive therapy improves symptom control and quality of life in IBD, as recommended by the European Gastroenterology society 13
Addressing anxiety and depression pharmacologically when present associates with improved outcomes, including reduced hospitalization, according to the European Gastroenterology society 13
Stress reduction should complement rather than replace anti-inflammatory therapy in established IBD, as noted by the American Gastroenterological Association and the European Gastroenterology society 12, 13